Rebecca Warwick currently serves as the Director of Regulatory Affairs at Astria Therapeutics, Inc., since February 2024. Previously, Rebecca held the position of Associate Director of Regulatory Affairs at Sage Therapeutics from October 2016 to September 2023, and also worked as a Manager in Regulatory Affairs within the same company. Prior experience includes Senior Regulatory Affairs Associate at Alkermes, Regulatory Operations Specialist at ARIAD Pharmaceuticals, Regulatory Affairs Consultant at Shire HGT, and various regulatory roles at FoldRx Pharmaceuticals and EPIX Pharmaceuticals. Rebecca holds a Master of Public Health in Health Services Management & Policy from Tufts University School of Medicine and a Bachelor's degree in English and Hispanic Studies from Wheaton College Massachusetts.